HAFNIA ALVEI FORMULATIONS

Hafnia alvei Hafnia alvei −4 Hafnia alvei A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Col...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TARGEDYS, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE), UNIVERSITÉ DE ROUEN, CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN
Format:	Patent
Sprache:	eng
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	TARGEDYS INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) UNIVERSITÉ DE ROUEN CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN
description	Hafnia alvei Hafnia alvei −4 Hafnia alvei A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Colony Forming Units to the total cell number ranges from 10to 0.8. Also, oral dosage forms, namely gastro-resistant capsules including the composition of essentially made of a probiotic strain expressing the ClpB protein.
format	Patent
fullrecord	<record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_17290385</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20210401020</sourcerecordid><originalsourceid>FETCH-uspatents_applications_172903853</originalsourceid><addsrcrecordid>eNrjZJD0cHTz83RUcPQJc_VUcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDGpuriHOHrqlxQWJJal5JcXxiQUFOZnJiSWZ-XnF8YbmRpYGxhamxkQrBADZcCXr</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HAFNIA ALVEI FORMULATIONS</title><source>USPTO Published Applications</source><creator>TARGEDYS ; INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) ; UNIVERSITÉ DE ROUEN ; CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creator><creatorcontrib>TARGEDYS ; INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) ; UNIVERSITÉ DE ROUEN ; CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creatorcontrib><description>Hafnia alvei Hafnia alvei −4 Hafnia alvei A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Colony Forming Units to the total cell number ranges from 10to 0.8. Also, oral dosage forms, namely gastro-resistant capsules including the composition of essentially made of a probiotic strain expressing the ClpB protein.</description><language>eng</language><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20210401020$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,869,881,64032</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/17290385$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TARGEDYS</creatorcontrib><creatorcontrib>INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)</creatorcontrib><creatorcontrib>UNIVERSITÉ DE ROUEN</creatorcontrib><creatorcontrib>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creatorcontrib><title>HAFNIA ALVEI FORMULATIONS</title><description>Hafnia alvei Hafnia alvei −4 Hafnia alvei A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Colony Forming Units to the total cell number ranges from 10to 0.8. Also, oral dosage forms, namely gastro-resistant capsules including the composition of essentially made of a probiotic strain expressing the ClpB protein.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZJD0cHTz83RUcPQJc_VUcPMP8g31cQzx9PcL5mFgTUvMKU7lhdLcDGpuriHOHrqlxQWJJal5JcXxiQUFOZnJiSWZ-XnF8YbmRpYGxhamxkQrBADZcCXr</recordid><startdate>20191128</startdate><enddate>20191128</enddate><creator>TARGEDYS</creator><creator>INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)</creator><creator>UNIVERSITÉ DE ROUEN</creator><creator>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creator><scope>EFI</scope></search><sort><creationdate>20191128</creationdate><title>HAFNIA ALVEI FORMULATIONS</title></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_172903853</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>online_resources</toplevel><creatorcontrib>TARGEDYS</creatorcontrib><creatorcontrib>INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)</creatorcontrib><creatorcontrib>UNIVERSITÉ DE ROUEN</creatorcontrib><creatorcontrib>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><aucorp>TARGEDYS</aucorp><aucorp>INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE)</aucorp><aucorp>UNIVERSITÉ DE ROUEN</aucorp><aucorp>CENTRE HOSPITALIER UNIVERSITAIRE DE ROUEN</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HAFNIA ALVEI FORMULATIONS</title><date>2019-11-28</date><risdate>2019</risdate><abstract>Hafnia alvei Hafnia alvei −4 Hafnia alvei A composition essentially made of a Hafnia alvei probiotic strain expressing the ClpB protein; wherein the ClpB protein is in an amount of at least 0.7% (w/w) in weight relative to the total weight of the composition; and the ratio of the total number of Colony Forming Units to the total cell number ranges from 10to 0.8. Also, oral dosage forms, namely gastro-resistant capsules including the composition of essentially made of a probiotic strain expressing the ClpB protein.</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_uspatents_applications_17290385
source	USPTO Published Applications
title	HAFNIA ALVEI FORMULATIONS
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T18%3A19%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.aucorp=TARGEDYS&rft.date=2019-11-28&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20210401020%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true